Previous studies have demonstrated that the formation of spatial, contextual and trace conditioning memories are impaired in animal models of Alzheimer's disease (AD), consistent with the observations that the first sign of cognitive decline in AD includes difficulties in the acquisition of new information or memory formation. Evidence is accumulating that memory retrieval is a dynamic process in which stored information becomes labile again and needs to be restabilized. However, it is poorly understood how this process referred to as memory reconsolidation is affected in animal models of AD. The present study was designed to use contextual fear conditioning to compare the changes in memory formation and subsequent reconsolidation processes in transgenic mice that overexpress human APP and PS1 harboring five familial AD mutations (5XFAD model). The results clearly demonstrate that cognitive dysfunction starts to occur primarily as reduced levels of contextual learning or memory formation in 5XFAD mice, but it is exacerbated by additional retrieval-dependent retrograde amnesia due to deficient reconsolidation as disease further develops.
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Transgenic animal models of Alzheimer's disease (AD) have made considerable contribution to our understanding of molecular and pathophysiological mechanisms of AD and related cognitive dysfunctions. Although to date no perfect model of AD has emerged, the mice that overexpress mutant forms of human amyloid precursor protein (APP), presenilin (PS) and/or tau genes successfully recapitulate many features of AD including b-amyloid (Ab) deposits, neurofibrillary tangles, gliosis and synaptic degeneration, and exhibit memory deficits as evidenced by their poor performances on a broad battery of behavioral assays such as Morris water maze, Y-maze, fear conditioning and object or social recognition tasks (Ashe, 2001; Eriksen & Janus, 2007; Gotz & Ittner, 2008; Kobayashi & Chen, 2005; LaFerla & Oddo, 2005; McGowan, Eriksen, & Hutton, 2006; Ohno, 2006) . However, these studies predominantly tested the acquisition of learning or memories shortly after training, and it remains unclear whether a subsequent prolonged period of memory reorganization is affected in APP transgenic mice. While new memories are stabilized after initial learning through a process called consolidation, it has become increasingly apparent that retrieval or reactivation of previously consolidated memories induces an additional labile phase during which the memories can be modified or strengthened (Eisenberg, Kobilo, Berman, & Dudai, 2003; Lee, 2008; Nader, Schafe, & Le Doux, 2000; Tronson, Wiseman, Olausson, & Taylor, 2006) . This process named reconsolidation requires molecular mechanisms or brain regions that are not necessarily the same as those of initial memory consolidation, representing an important distinctive component of long-term memory processing (Alberini, 2005; Dudai, 2006; Lee, Everitt, & Thomas, 2004; Nader, 2003; Suzuki et al., 2004; Tronson & Taylor, 2007) . To test the hypothesis that disrupted reconsolidation may be involved in AD-related memory dysfunction, I used a contextual fear conditioning paradigm and examined the effects of cerebral Ab accumulation on memory reconsolidation in AD transgenic model mice, as compared to those on their initial hippocampal memory formation.
We previously reported that 5XFAD APP/PS1 transgenic mice (Tg6799 line) containing five familial AD (FAD) mutations represent one of the most early-onset and aggressive amyloid mouse models (Oakley et al., 2006; Ohno et al., 2006 Ohno et al., , 2007 . 5XFAD mice are engineered to co-overexpress and co-inherit mutant human APP (the Swedish mutation: K670N, M671L; the Florida mutation: I716V; the London mutation: V717I) and PS1 (M146L; L286V) transgenes under neuron-specific mouse Thy-1 promoter. In the 5XFAD mouse model, the Swedish mutation increases the production of total Ab while the other four mutations specifically increase the production of Ab42. Consequently, five FAD mutations act together to additively increase levels of cerebral Ab peptides, especially neurotoxic Ab42. 5XFAD lines (B6/SJL genetic background) were maintained by crossing hemizygous transgenic mice with B6/SJL F1 breeders (Taconic, Hudson, NY), and 5XFAD hemizygotes were used for the experiments with non-transgenic wild-type littermate mice served as controls. While the majority of AD transgenic mice take $6-12 months, or longer, to form amyloid plaques (Eriksen & Janus, 2007) , 5XFAD mice start to develop visible amyloid deposits as early as $2 months of age consistent with
